Biological and surface-active properties of double-chain cationic amino acid-based surfactants

Amino Acids

Volumn 46, Issue 8, 2014, Pages 1893-1898

  Greber, Katarzyna E ^a   Dawgul, Małgorzata ^a   Kamysz, Wojciech ^a   Sawicki, Wiesław ^a   Łukasiak, Jerzy ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Antimicrobial activity; Critical micelle concentration; Lipopeptides; Surfactants

Indexed keywords

CATIONIC SURFACTANT; LIPOPEPTIDE; N ALPHA DECANOYL N EPSILON DECANOYL LYSYLLYSYLLYSYLLYSINE DERIVATIVE; N ALPHA DODECANOYL N EPSILON DODECANOYL LYSYLLYSYLLYSYLLYSINE DERIVATIVE; N ALPHA HEXADECANOYL N EPSILON HEXADECANOYL LYSYLLYSYLLYSYLLYSINE DERIVATIVE; N ALPHA OCTANOYL N EPSILON EOCTANOYL LYSYLLYSYLLYSYLLYSINE DERIVATIVE; N ALPHA TETRADECANOYL N EPSILON TETRADECANOYL LYSYLLYSYLLYSYLLYSINE DERIVATIVE; UNCLASSIFIED DRUG; AMINO ACID; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; FATTY ACID; MICELLE; SURFACTANT;

ACYLATION; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS SUBTILIS; BACTERIAL STRAIN; CANDIDA ALBICANS; CANDIDA TROPICALIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG POTENCY; DRUG SENSITIVITY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; EUKARYOTIC CELL; FUNGAL STRAIN; HEMOLYSIS; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; MICELLE; MICELLIZATION; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURFACE TENSION; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MICROBIAL SENSITIVITY TEST; SOLID PHASE SYNTHESIS;

BACTERIA (MICROORGANISMS); EUKARYOTA; FUNGI; NEGIBACTERIA; POSIBACTERIA;

ACYLATION; AMINO ACIDS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; DRUG DESIGN; FATTY ACIDS; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; LIPOPEPTIDES; MICELLES; MICROBIAL SENSITIVITY TESTS; SOLID-PHASE SYNTHESIS TECHNIQUES; SURFACE-ACTIVE AGENTS;

EID: 84904743950     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-014-1744-9     Document Type: Article

References (21)

1. Brito RO, Marques EF, Silva SG, do Vale ML, Gomes P, Araújo MJ, Rodriguez-Borges JE, Infante MR, Garcia MT, Ribosa I, Vinardell MP, Mitjans M (2009) Physicochemical and toxicological properties of novel amino acid-based amphiphiles and their spontaneously formed cationic vesicles. Colloids Surf B Biointerfaces 72(1):80-87
2. Brito RO, Silva SG, Fernandes RM, Marques EF, Enrique-Borges J, do Vale ML (2011) Enhanced interfacial properties of novel amino acid-derived surfactants: effects of headgroup chemistry and of alkyl chain length and unsaturation. Colloids Surf B Biointerfaces 86(1):65-70
3. Carpino LA (1987) The 9-fluorenylmethyloxycarbonyl family of base-sensitive amino-protecting group. Acc Chem Res 20(11):401-407
4. Chan WC, White PD (2004) Fmoc solid phase peptide synthesis. A practical approach. Oxford University Press, New York
5. Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS (2007) Role of peptide hydrophobicity in the mechanism of action of α-helical antimicrobial peptides. Antimicrob Agents Chemother 51(4):1398-1406 (Pubitemid 46586822)
6. Christensen T (1979) Qualitative test for monitoring coupling completeness in solid phase peptide synthesis using chloranil. Acta Chem Scand Ser B 33:763-776
7. CLSI (2009) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th edn
8. CLSI (2010) Performance standards for antimicrobial susceptibility testing. 20th informational supplement
9. Denyer SP, Baird RM (2007) Guide to microbiological control in pharmaceuticals and medical devices. CRC Press, New York
10. Fields GB (1994) Methods for removing the Fmoc group. Methods Mol Biol 35:17-27
11. Fields GB, Noble RL (1990) Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 35(3):161-214 (Pubitemid 20126875)
12. Findlay B, Zhanel GG, Schweizer F (2012) Investigating the antimicrobial peptide 'window of activity' using cationic lipopeptides with hydrocarbon and fluorinated tails. Int J Antimicrob Agents 40(1):36-42
13. Jiang Z, Vasil AI, Hale J, Hancock RE, Vasil ML, Hodges RS (2008) Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α-helical cationic antimicrobial peptides. Biopolymers 90(3):369-383
14. König W, Geiger R (1970) A new method for synthesis of peptides: activation of the carboxyl group with dicyclohexylcarbodiimide using 1-hydroxybenzotriazoles as additives. Chem Ber 103(3):788-798
15. Merrifield RB (1963) Solid phase peptide synthesis. The synthesis of a tetrapeptide. J Am Chem Soc 85(14):2149-2154
16. Meyer BK, Ni A, Hu B, Shi L (2007) Antimicrobial preservative use in parenteral products: past and present. J Pharm Sci 96(12):3155-3167
17. Sánchez L, Mitjans M, Infante MR, García MT, Manresa MA, Vinardell MP (2007) The biological properties of lysine-derived surfactants. Amino Acids 32(1):133-136 (Pubitemid 44866579)
18. Sarig H, Rotem S, Ziserman L, Danino D, Mor A (2008) Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers. Antimicrob Agents Chemother 52(12):4308-4314
19. Shai Y (2002) Mode of action of membrane active antimicrobial peptides. Biopolymers 66(4):236-248
20. Tossi A, Sandri L, Giangaspero A (2000) Amphipathic, α-helical antimicrobial peptides. Biopolymers 55(1):4-30
21. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415(6870):389-395